GSK mulls filings for multiple myeloma drug

GSK mulls filings for multiple myeloma drug

Source: 
Pharmaforum
snippet: 

GlaxoSmithKline has announced more data making the case for its multiple myeloma antibody-drug conjugate GSK2857916, confirming that almost two thirds of patients responded to the drug after an extra year’s follow-up.